Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
- 12 March 2009
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 34 (2), 371-379
- https://doi.org/10.1183/09031936.00106008
Abstract
Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a worse prognosis and response to pulmonary arterial hypertension (PAH) therapy than idiopathic PAH (IPAH). These differences have not yet been explained. Knowledge concerning histological pulmonary vasculopathy in SScPAH is limited in contrast to IPAH. Therefore, we explored patterns of vasculopathy in SScPAH compared with IPAH. Parameters of vasculopathy were assessed from lung tissue of eight PAH patients with limited cutaneous systemic sclerosis and 11 IPAH patients. Lung tissue was obtained at autopsy (n = 15), explantation (n = 3) and biopsy (n = 1). Pulmonary arterial/arteriolar intimal fibrosis was identified in all SScPAH patients and in three IPAH patients (p = 0.003). Fibrosis of pulmonary veins/venules was found in all SScPAH patients and in three IPAH patients (p = 0.003). In four SScPAH patients, fibrosis of veins/venules was focal and associated with capillary congestion as in pulmonary veno-occlusive disease (PVOD). Of the IPAH patients, 10 had unequivocal evidence of plexogenic arteriopathy compared with none of the SScPAH patients (p = 0.001). SScPAH is characterised by small vessel intimal fibrosis, which is associated with a PVOD-like pattern in some cases. This might explain its different clinical behaviour from IPAH. Small vessel intimal fibrosis may provide clues to elucidation of differences in pathogenetic mechanisms between the groups.Keywords
This publication has 42 references indexed in Scilit:
- Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- Clinical differences between idiopathic and scleroderma‐related pulmonary hypertensionArthritis & Rheumatism, 2006
- Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter studyArthritis & Rheumatism, 2005
- Long-Term Outcome of Bosentan Treatment in Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated with the Scleroderma Spectrum of DiseasesThe Journal of Heart and Lung Transplantation, 2005
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic SclerosisAnnals of Internal Medicine, 2004
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals Of The Rheumatic Diseases, 2003
- Pulmonary function in primary pulmonary hypertensionJournal of the American College of Cardiology, 2003
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis & Rheumatism, 2003
- Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003